BIXT
Price
$0.11
Change
-$0.00 (-0.00%)
Updated
Jun 27 closing price
Capitalization
9.39M
CING
Price
$4.07
Change
-$0.03 (-0.73%)
Updated
Jun 27 closing price
Capitalization
17.32M
Interact to see
Advertisement

BIXT vs CING

Header iconBIXT vs CING Comparison
Open Charts BIXT vs CINGBanner chart's image
Bioxytran
Price$0.11
Change-$0.00 (-0.00%)
Volume$38.01K
Capitalization9.39M
Cingulate
Price$4.07
Change-$0.03 (-0.73%)
Volume$48.61K
Capitalization17.32M
BIXT vs CING Comparison Chart in %
Loading...
BIXT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CING
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BIXT vs. CING commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIXT is a Hold and CING is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (BIXT: $0.11 vs. CING: $4.05)
Brand notoriety: BIXT and CING are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BIXT: 25% vs. CING: 28%
Market capitalization -- BIXT: $9.39M vs. CING: $17.2M
BIXT [@Biotechnology] is valued at $9.39M. CING’s [@Biotechnology] market capitalization is $17.2M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIXT’s FA Score shows that 0 FA rating(s) are green whileCING’s FA Score has 0 green FA rating(s).

  • BIXT’s FA Score: 0 green, 5 red.
  • CING’s FA Score: 0 green, 5 red.
According to our system of comparison, CING is a better buy in the long-term than BIXT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIXT’s TA Score shows that 1 TA indicator(s) are bullish while CING’s TA Score has 3 bullish TA indicator(s).

  • BIXT’s TA Score: 1 bullish, 6 bearish.
  • CING’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, CING is a better buy in the short-term than BIXT.

Price Growth

BIXT (@Biotechnology) experienced а -3.19% price change this week, while CING (@Biotechnology) price change was -2.17% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CING($17.3M) has a higher market cap than BIXT($9.39M). BIXT YTD gains are higher at: 17.375 vs. CING (-17.444). BIXT has higher annual earnings (EBITDA): -2.38M vs. CING (-15.75M). CING has more cash in the bank: 9.52M vs. BIXT (4.35K). BIXT has less debt than CING: BIXT (1.26M) vs CING (5.08M). BIXT (0) and CING (0) have equivalent revenues.
BIXTCINGBIXT / CING
Capitalization9.39M17.3M54%
EBITDA-2.38M-15.75M15%
Gain YTD17.375-17.444-100%
P/E RatioN/AN/A-
Revenue00-
Total Cash4.35K9.52M0%
Total Debt1.26M5.08M25%
FUNDAMENTALS RATINGS
BIXT: Fundamental Ratings
BIXT
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BIXTCING
RSI
ODDS (%)
Bullish Trend 3 days ago
72%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
78%
Bullish Trend 3 days ago
89%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
88%
MACD
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 3 days ago
82%
Advances
ODDS (%)
N/A
Bullish Trend 20 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BIXT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CING
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CBRE139.381.29
+0.93%
Cbre Group
MRKR1.46N/A
N/A
Marker Therapeutics
TFSL12.93-0.07
-0.54%
TFS Financial Corp
BTDR11.09-0.12
-1.07%
Bitdeer Technologies Group
ALTO1.14-0.02
-1.72%
Alto Ingredients

BIXT and

Correlation & Price change

A.I.dvisor tells us that BIXT and CING have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BIXT and CING's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIXT
1D Price
Change %
BIXT100%
-5.70%
CING - BIXT
26%
Poorly correlated
-0.73%
CYTK - BIXT
22%
Poorly correlated
-2.21%
APLM - BIXT
21%
Poorly correlated
+1.51%
ANEB - BIXT
20%
Poorly correlated
+2.11%
TTNP - BIXT
20%
Poorly correlated
-1.79%
More

CING and

Correlation & Price change

A.I.dvisor indicates that over the last year, CING has been loosely correlated with GOVX. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if CING jumps, then GOVX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CING
1D Price
Change %
CING100%
-0.73%
GOVX - CING
39%
Loosely correlated
+1.04%
BEIGF - CING
28%
Poorly correlated
N/A
BIXT - CING
26%
Poorly correlated
-5.70%
CYTK - CING
26%
Poorly correlated
-2.21%
GRCE - CING
22%
Poorly correlated
+1.02%
More